Mustang Bio (MBIO) Operating Expenses (2016 - 2026)

Mustang Bio (MBIO) has reported Operating Expenses for 11 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 32.2% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $3.5 million, a 2.49% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 85.03% from the prior year.
• Operating Expenses was $1.2 million for Q2 2026 at Mustang Bio, up from $1.1 million in the prior quarter.
• Over five years, Operating Expenses peaked at $19.6 million in Q1 2022 and troughed at $253000.0 in Q1 2025.
• A 5-year average of $8.1 million and a median of $6.9 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses sank 95.16% in 2025 and soared 318.18% in 2026, its largest moves.
• Over 5 years, Operating Expenses stood at $19.4 million in 2022, then tumbled by 55.02% to $8.7 million in 2023, then sank by 88.37% to $1.0 million in 2024, then sank by 34.12% to $670000.0 in 2025, then soared by 74.63% to $1.2 million in 2026.
• The last three Operating Expenses figures came in at $1.2 million (Q2 2026), $1.1 million (Q1 2026), and $670000.0 (Q4 2025), per Business Quant data.